Authors response to Letter re: The pathway alteration load is a pan-cancer determinant of outcome of targeted therapies: results from the Drug Rediscovery Protocol (DRUP) molecular complexity and response to targeted therapy.
K Verkerk
,
E E Voest
More about this publication
ESMO open
Volume
10
Issue nr.
4
Pages
104515
Publication date
01-04-2025
Full text links
Publisher website (DOI)
10.1016/j.esmoop.2025.104515
Europe PubMed Central
40112697
Pubmed
40112697